A 2026 qualitative study of 60 patients in the ACHIEVE-3 clinical trial found that orforglipron, a new oral diabetes medication, delivered benefits beyond blood sugar control and weight loss. Patients reported increased energy (47%), reduced appetite and cravings (38%), improved mood and confidence (30%), and better ability to exercise (30%), with 98% expressing satisfaction and willingness to continue the medication.
Researchers interviewed 60 people with type 2 diabetes who took a new oral medication called orforglipron in a clinical trial. Beyond lowering blood sugar and helping people lose weight, patients reported feeling more energetic, having fewer food cravings, exercising more, and feeling better about themselves. According to Gram Research analysis, nearly all patients were satisfied with the treatment and wanted to keep taking it. These findings suggest the medication offers benefits that go beyond what traditional blood tests measure, potentially improving people’s overall quality of life.
Key Statistics
A 2026 qualitative study of 60 patients with type 2 diabetes found that 98% were satisfied with orforglipron treatment and wanted to continue taking it, with 88% reporting improved blood sugar control and 83% reporting weight loss averaging 4.7 kilograms.
According to research reviewed by Gram, 47% of patients taking orforglipron in the ACHIEVE-3 trial reported increased energy levels, while 38% experienced reduced appetite and food cravings, and 30% reported improvements in mood and self-confidence.
In a 2026 analysis of 60 diabetes patients, those taking the new oral medication orforglipron reduced their blood sugar levels by an average of 1.6% and reported improvements in exercise ability (30%), sleep quality, and vision stability beyond traditional clinical measures.
The Quick Take
- What they studied: How patients felt about taking a new type 2 diabetes pill called orforglipron, including benefits beyond just lowering blood sugar and weight loss
- Who participated: 60 people with type 2 diabetes, average age 59 years, about half were women, who had the disease for an average of 8.5 years and completed at least 3 months of treatment in a clinical trial
- Key finding: Beyond controlling blood sugar and losing weight, 47% of patients reported feeling more energetic, 38% had fewer food cravings, and 30% said their mood and confidence improved
- What it means for you: If you have type 2 diabetes, this medication may help you feel better in ways that go beyond what your doctor’s blood tests show, like having more energy and feeling more confident about yourself
The Research Details
Researchers conducted one-on-one interviews with 60 patients who had completed at least 3 months of treatment with a new diabetes medication in a larger clinical trial called ACHIEVE-3. The interviews were done at ten different medical centers across the United States and were conducted in English or Spanish. Each interview was recorded and written down word-for-word, then carefully reviewed to identify and count the positive changes patients mentioned.
This approach is called qualitative research, which means the researchers focused on understanding patients’ personal experiences and stories rather than just looking at numbers. The researchers then counted how many patients mentioned each type of benefit to see which improvements were most common.
This method is valuable because it captures how patients actually feel about their treatment in their own words, revealing benefits that standard medical tests might miss, like improved energy levels or better mood.
Most diabetes studies focus only on blood sugar control and weight loss because these are easy to measure with tests. However, patients care about how the medication makes them feel in their daily lives. By asking patients directly about their experiences, researchers discovered that this new medication may improve people’s quality of life in multiple ways, which could help doctors and patients make better treatment decisions.
This study has several strengths: all 60 patients who started the interviews completed them, showing good participation; the interviews were conducted at multiple medical centers across the country; and patients were asked open-ended questions so they could share their own experiences rather than just answering yes-or-no questions. However, this study only looked at patients’ positive experiences, not negative side effects or problems they experienced. Additionally, the study was relatively small with only 60 patients, so the results may not apply to everyone with type 2 diabetes.
What the Results Show
Nearly all patients reported satisfaction with the medication. Fifty-nine out of 60 patients said they were satisfied, 59 out of 60 said they would recommend it to others, and 59 out of 60 said they wanted to keep taking it. These high satisfaction rates suggest the medication was well-tolerated and effective from the patients’ perspective.
The most commonly reported benefits were the ones doctors typically measure: 88% of patients mentioned better blood sugar control, and 83% mentioned weight loss. On average, patients’ blood sugar control improved by 1.6%, and they lost about 4.7 kilograms (about 10 pounds).
Beyond these standard medical measures, patients reported many other positive changes. Nearly half the patients (47%) said they felt more energetic. About 38% reported having fewer cravings for food and feeling less hungry. Thirty percent said they were able to exercise or move around more easily. Another 30% reported improvements in their mood, confidence, or self-esteem.
Patients also mentioned other benefits including better eating habits, improved sleep quality, and either improved vision or no worsening of their eyesight. All of these changes were considered meaningful and important by the patients themselves.
Beyond the main benefits, patients reported improvements in several other areas of their lives. Some patients mentioned developing more confidence and higher self-esteem, which could help them feel better about managing their diabetes. Others described improvements in their diet and eating habits, suggesting the medication may help people make healthier food choices. Several patients reported sleeping better at night. A few patients also noted that their vision either improved or stayed the same rather than getting worse, which is important because diabetes can sometimes damage eyesight over time.
This study adds important new information to what we know about GLP-1 receptor agonist medications, a class of drugs that includes popular diabetes treatments. Previous research has shown these medications work well for controlling blood sugar and helping people lose weight. This new study confirms those benefits and goes further by showing that patients experience improvements in energy, appetite control, exercise ability, and mood. These additional benefits had not been thoroughly documented in previous patient interviews, making this research a valuable addition to our understanding of how these medications affect people’s lives.
This study only looked at patients who completed at least 3 months of treatment and were willing to participate in interviews, which means it may not include people who stopped taking the medication or had negative experiences. The study did not systematically ask about side effects or problems, so we don’t have complete information about all the challenges patients faced. With only 60 patients from ten medical centers in the United States, the results may not apply to people in other countries or different populations. Additionally, because this was a qualitative study focused on positive experiences, it provides less detailed statistical information than some other types of research.
The Bottom Line
If you have type 2 diabetes and your doctor recommends orforglipron or similar medications, this research suggests you may experience benefits beyond just better blood sugar control, including increased energy, reduced hunger, improved mood, and better ability to exercise. Talk with your doctor about whether this medication is right for you, as individual results vary. This evidence is moderately strong because it comes from a structured clinical trial with high patient satisfaction rates, though more research with larger groups is needed.
This research is most relevant for people with type 2 diabetes who are considering treatment options and want to understand the full range of potential benefits. It’s also important for doctors and healthcare providers who counsel patients about diabetes medications. People with type 1 diabetes or other types of diabetes should not assume these results apply to them. Anyone with kidney disease, heart problems, or a personal or family history of thyroid cancer should discuss this medication carefully with their doctor before starting.
Based on this study, patients experienced meaningful improvements within 3 months of starting the medication. However, individual results vary, and some benefits like increased energy or improved mood may develop gradually over several weeks. It typically takes 2 to 4 weeks to notice changes in appetite and hunger. Blood sugar improvements can be measured within weeks, but weight loss usually becomes noticeable over 2 to 3 months.
Frequently Asked Questions
What are the benefits of orforglipron beyond lowering blood sugar?
Patients reported increased energy (47%), fewer food cravings (38%), improved mood and confidence (30%), and better ability to exercise (30%). These quality-of-life improvements occurred alongside blood sugar control and weight loss averaging 4.7 kilograms.
How satisfied were patients with orforglipron in the clinical trial?
Nearly all patients were satisfied: 98% expressed satisfaction with the medication, 98% said they would recommend it to others, and 98% wanted to continue taking it after the trial ended.
How much weight did patients lose on orforglipron?
Patients lost an average of 4.7 kilograms (about 10 pounds) over the study period. Individual results varied, with some patients losing more and others losing less, depending on their starting weight and other factors.
How quickly do patients feel the benefits of orforglipron?
This study followed patients for at least 3 months, during which they experienced meaningful improvements in energy, appetite, mood, and exercise ability. Benefits typically develop gradually over weeks rather than appearing immediately.
Is orforglipron safe for everyone with type 2 diabetes?
This study showed high satisfaction and willingness to continue, suggesting good tolerability. However, individual responses vary. People with kidney disease, heart problems, or thyroid cancer history should discuss this medication with their doctor before starting, as it may not be appropriate for everyone.
Want to Apply This Research?
- Track your energy levels daily on a scale of 1 to 10, along with your appetite level and how many times you exercised or moved around. Record these weekly to see if they improve over time as you take the medication.
- Use the app to set a goal to increase physical activity by 10 minutes per week, since this study showed patients were able to exercise more. Log your workouts and celebrate small wins to build confidence and momentum.
- Create a monthly check-in where you rate your overall mood, confidence, sleep quality, and energy levels. Compare these ratings month-to-month to track improvements in quality of life beyond what your doctor’s blood tests measure. Share these observations with your healthcare provider at your next appointment.
This research describes patient experiences with orforglipron in a clinical trial setting. Individual results vary, and this medication may not be appropriate for everyone. People with a personal or family history of thyroid cancer, kidney disease, heart problems, or who are pregnant or breastfeeding should not take this medication without consulting their healthcare provider. Always discuss any new diabetes treatment with your doctor before starting, and do not stop taking current medications without medical guidance. This article is for educational purposes and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.